Showing results (941-950 of 3,020) with videos related to
Sort By:
Pageof 302
Current Pharmaceutical Biotechnology|May 29, 2018
Genetic Variants of CYP2R1 Are Key Regulators of Serum Vitamin D Levels and Incidence of Myocardial Infarction in Middle-Aged EgyptiansNada K Sedky, Mohamed F Abdel Rahman, Sally I Hassanein, et al.Current Pharmaceutical Biotechnology|April 7, 2011
Mechanisms underlying the anti-proliferative effects of berry components in in vitro models of colon cancerEmma M Brown, Chris I R Gill, Gordon J McDougall, et al.Current Pharmaceutical Biotechnology|April 7, 2011
Biological activity of carotenoids: its implications in cancer risk and preventionMary Chatterjee, Kaushik Roy, M Janarthan, et al.Current Pharmaceutical Biotechnology|April 7, 2011
Crocetin: an agent derived from saffron for prevention and therapy for cancerWilliam G Gutheil, Gregory Reed, Amitabha Ray, et al.Current Pharmaceutical Biotechnology|April 7, 2011
Cancer chemoprevention by dietary phytochemicals: promises and pitfallsRamamurthi Vidya Priyadarsini, Siddavaram NaginiCurrent Pharmaceutical Biotechnology|April 7, 2011
Alteration of hepatic proinflammatory cytokines is involved in the resveratrol-mediated chemoprevention of chemically-induced hepatocarcinogenesisThomas Mbimba, Prabha Awale, Deepak Bhatia, et al.Current Pharmaceutical Biotechnology|April 7, 2011
Biologic drugs for analgesia: redefining the opportunityJane Hughes, Jonathan P Hatcher, Iain P ChessellCurrent Pharmaceutical Biotechnology|April 7, 2011
The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradationL J Alvarez-Jaimes, J A PalmerCurrent Pharmaceutical Biotechnology|April 7, 2011
Rodent models of persistent pain in drug discovery and developmentWilliam A EckertCurrent Pharmaceutical Biotechnology|April 7, 2011
How unbiased is non-targeted metabolomics and is targeted pathway screening the solution?Uwe Christians, Jelena Klawitter, Andrea Hornberger, et al.Pageof 302